Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proof of Concept Study”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00322803
What this trial is testing

ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment

Who this might be right for
Panic Disorder
elbion AG 24
Not applicableStudy completedNCT07547761
What this trial is testing

A Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy Adults

Who this might be right for
Body Odor
Kingdom 5
Testing effectiveness (Phase 2)Study completedNCT01200290
What this trial is testing

A Study in Participants With End-Stage Renal Disease

Who this might be right for
Kidney Failure, Chronic
Eli Lilly and Company 18
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Testing effectiveness (Phase 2)Looking for participantsNCT06209736
What this trial is testing

Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Who this might be right for
C3 GlomerulopathyIdiopathic Immune Complex-Mediated Glomerulonephritis
Omeros Corporation 20
Testing effectiveness (Phase 2)Ended earlyNCT02231580
What this trial is testing

Study Exploring Safety, Pharmacokinetic and Pharmacodynamic of BN82451 in Male Huntington's Disease Patients

Who this might be right for
Huntington's Disease
Ipsen 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05504187
What this trial is testing

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Kira Pharmacenticals (US), LLC. 24
Not applicableStudy completedNCT02004314
What this trial is testing

Chloroquine as a Modulator of T Cell Immune Activation

Who this might be right for
HIV
CIHR Canadian HIV Trials Network 19
Testing effectiveness (Phase 2)Study completedNCT00739739
What this trial is testing

An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

Who this might be right for
Interstitial CystitisPainful Bladder Syndrome
Pfizer 161
Testing effectiveness (Phase 2)Study completedNCT00528905
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 400
Post-approval studies (Phase 4)Study completedNCT05780151
What this trial is testing

Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

Who this might be right for
Diabetes Mellitus, Type 2
Mira Zuidgeest 107
Early research (Phase 1)WithdrawnNCT00916201
What this trial is testing

Evaluation Study of New Compounds With Potential Use in Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim
Not applicableStudy completedNCT03723512
What this trial is testing

Non-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 Study

Who this might be right for
C3 GlomerulonephritisC3 GlomerulopathyImmune Complex Membranoproliferative Glomerulonephritis+2 more
Mario Negri Institute for Pharmacological Research 7
Very early researchStudy completedNCT01729598
What this trial is testing

Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study

Who this might be right for
Alzheimer's Disease
Gregory Jicha, 323-5550 14
Testing effectiveness (Phase 2)Study completedNCT06028438
What this trial is testing

Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Janssen Research & Development, LLC 103
Testing effectiveness (Phase 2)Study completedNCT00389298
What this trial is testing

A Proof-of-concept Study of VCH-759 for the Treatment of Hepatitis C-infection.

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 36
Not applicableUnknownNCT05693012
What this trial is testing

Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Qiu Lugui 398
Testing effectiveness (Phase 2)Looking for participantsNCT07546929
What this trial is testing

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Housey Healthcare ULC 300
Post-approval studies (Phase 4)WithdrawnNCT03761953
What this trial is testing

Oritavancin for Staphylococcus Aureus Infections in Opioid Users

Who this might be right for
Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
University of Pennsylvania
Not applicableStudy completedNCT06805201
What this trial is testing

The Effects of Gyngerlean Supplementation on Energy Expenditure

Who this might be right for
No Disease or Condition is Being StudiedMetabolism
Nova Southeastern University 10
Next Page